Table 1 Relationship between SCL7A11 expression and clinicopathological factors of HCC patients
Factors | Total | SLC7A11 | P value | |
|---|---|---|---|---|
Low | High (%) | |||
Age (years) | ||||
 < 45 | 11 | 6 | 5 (45.5) | > 0.99 |
 ≥ 45 | 20 | 12 | 8 (40.0) | |
Gender | ||||
 Male | 25 | 15 | 10 (40.0) | 0.676 |
 Female | 6 | 3 | 3 (50.0) | |
TNM stage | ||||
 I/II | 15 | 12 | 3 (20.0) | 0.029* |
 III/IV | 16 | 6 | 10 (62.5) | |
Pathology grade | ||||
 1/2 | 20 | 12 | 8 (40.0) | > 0.99 |
 3/4 | 11 | 6 | 5 (45.5) | |
Size | ||||
 < 5 cm | 17 | 13 | 4 (23.5) | 0.029* |
 ≥ 5 cm | 12 | 4 | 8 (66.7) | |
HBV infection | ||||
 With HBV | 5 | 5 | 0 (0) | 0.13 |
 Without HBV | 19 | 11 | 8 (42.1) | |
AFP | ||||
 < 400 ng/ml | 13 | 8 | 5 (38.5) | 0.685 |
 ≥ 400 ng/ml | 10 | 5 | 5 (50.0) | |